Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,870.00    -64.00 (-1.30%)
Bid:
4,866.00
Ask:
4,870.00
Spread: 4.00 (0.082%)
Market Cap: £17.75b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Syndicated Multi-Currency RCF

25 Jun 2015 14:51

RNS Number : 2639R
Coca-Cola HBC AG
25 June 2015
 



 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG and Coca-Cola HBC Finance B.V.

announce renewal of Syndicated Multi-Currency Revolving Credit Facility

25 June 2015 - Coca-Cola HBC AG ("Coca-Cola HBC" and, together with its subsidiaries, the "Group") and Coca-Cola HBC Finance B.V. announce the replacement of the Group's existing EUR 500,000,000 Syndicated Multi-Currency Revolving Credit Facility (the "Previous Facility"), which was set to expire in May 2016, with a new EUR 500,000,000 Syndicated Multi-Currency Revolving Credit Facility having a term of five years with a one-year extension option (the "Facility"). The Facility can be used for general corporate purposes. The Previous Facility has been cancelled.

Coca-Cola HBC Finance B.V. is the borrower under the Facility (the "Borrower"). The obligations of the Borrower under the Facility are guaranteed by both Coca-Cola HBC and Coca-Cola HBC Holdings B.V..

Deutsche Bank Luxembourg and ING acted as Co-ordinators for the Facility. The Bookrunner Mandated Lead Arrangers are BNP Paribas, Citi, Credit Suisse AG, Deutsche Bank Luxembourg, ING, Intesa Sanpaolo S.p.A., Société Générale and UniCredit Bank AG, and the Lead Arranger is Raiffeisen Bank International AG.

 

 

 

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

 

Tel: +41 41 726 0143

 basak.kotler@cchellenic.com

 

Eri Tziveli

Investor Relations Manager

Tel: +30 210 618 3133

 eri.tziveli@cchellenic.com

 

Nikos Efstathopoulos

Investor Relations Manager

Tel: +30 210 618 3260

 nikos.efstathopoulos@cchellenic.com

 

International media contact:

StockWell Communications

Rob Morgan

Ben Ullmann

Anushka Mathew

Tel: +44 20 7240 2486

 robert.morgan@stockwellgroup.com

 ben.ullmann@stockwellgroup.com

 anushka.mathew@stockwellgroup.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

 

About Coca‑Cola HBC

Coca-Cola HBC is the second-largest bottler of the brands of The Coca-Cola Company in terms of volume with sales of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 590 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). Coca-Cola HBC is included in the Dow Jones Sustainability and FTSE4Good Indexes. For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCXELFLEQFZBBK
Date   Source Headline
16th Mar 20182:41 pmRNSDirector/PDMR Shareholding
16th Mar 20189:07 amRNSAnnual Financial Report
9th Mar 20184:03 pmRNSDirector/PDMR Shareholding
1st Mar 201812:32 pmRNSIssue of equity and total voting rights
27th Feb 20181:05 pmRNSDirector/PDMR Shareholding
26th Feb 20183:33 pmRNSDirector/PDMR Shareholding
23rd Feb 201810:53 amRNSDirector/PDMR Shareholding
22nd Feb 20184:28 pmRNSHolding(s) in Company
22nd Feb 20183:02 pmRNSDirector/PDMR Shareholding
21st Feb 201810:21 amRNSDirector/PDMR Shareholding
21st Feb 201810:13 amRNSDirector/PDMR Shareholding
20th Feb 20182:16 pmRNSDirector/PDMR Shareholding
20th Feb 20181:31 pmRNSDirector/PDMR Shareholding
20th Feb 20181:19 pmRNSDirector/PDMR Shareholding
20th Feb 20181:00 pmRNSDirector/PDMR Shareholding
16th Feb 201811:22 amRNSDirector/PDMR Shareholding
14th Feb 20187:00 amRNSEXCEPTIONAL SET OF RESULTS
1st Feb 201810:35 amRNSIssue of equity and total voting rights
19th Jan 20184:02 pmRNSDirector/PDMR Shareholding
17th Jan 201811:05 amRNSNotice of Results
5th Jan 20184:02 pmRNSAthens Exchange trading date of ordinary shares
2nd Jan 201810:04 amRNSIssue of equity and total voting rights
20th Dec 20172:15 pmRNSDirector/PDMR Shareholding
7th Dec 20177:00 amRNSAppointment of Chief Executive Officer
1st Dec 20179:06 amRNSIssue of Equity and Total Voting Rights
20th Nov 201711:57 amRNSDirector/PDMR Shareholding
9th Nov 20177:00 amRNSCONTINUING TO DELIVER EXCELLENT REVENUE GROWTH
1st Nov 20179:07 amRNSIssue of Equity and Total Voting Rights
1st Nov 20178:55 amRNSBlock listing Interim Review
18th Oct 201712:55 pmRNSDirector/PDMR Shareholding
9th Oct 201711:45 amRNSNotice of Results
3rd Oct 20177:00 amRNSStatement re. Chief Executive Officer
2nd Oct 20179:27 amRNSIssue of Equity and Total Voting Rights
27th Sep 201711:13 amRNSDirector Declaration
19th Sep 20173:30 pmRNSDirector/PDMR Shareholding
15th Sep 20177:01 amRNSCEO's medical leave of absence
1st Sep 20179:30 amRNSIssue of Equity and Total Voting Rights
21st Aug 201711:37 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSEXCELLENT FIRST HALF RESULTS
1st Aug 20179:35 amRNSIssue of Equity and Total Voting Rights
28th Jul 20171:02 pmRNSDirector/PDMR Shareholding
19th Jul 20171:51 pmRNSDirector/PDMR Shareholding
4th Jul 201712:56 pmRNSNotice of Results
3rd Jul 20178:16 amRNSIssue of Equity and Total Voting Rights
21st Jun 20179:26 amRNSDirectorate Change
21st Jun 20179:15 amRNSResult of AGM
20th Jun 20173:00 pmRNSDirector/PDMR Shareholding
2nd Jun 201711:42 amRNSAthens Exchange trading date of ordinary shares
1st Jun 20177:54 amRNSIssue of Equity and Total Voting Rights
19th May 201712:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.